These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7926452)

  • 1. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit].
    Castera L; Pauwels A; Lévy VG
    Gastroenterol Clin Biol; 1996; 20(3):263-8. PubMed ID: 8763065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between zinc, amino acids and ammonia in liver cirrhosis.
    Grüngreiff K; Presser HJ; Franke D; Lössner B; Abicht K; Kleine FD
    Z Gastroenterol; 1989 Dec; 27(12):731-5. PubMed ID: 2626852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis.
    Rahelić D; Kujundzić M; Romić Z; Brkić K; Petrovecki M
    Coll Antropol; 2006 Sep; 30(3):523-8. PubMed ID: 17058518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolactin and estradiol levels in the plasma of patients with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; Zúñiga Pérez-Lemaur M; Valle Cagigas M; Leno Valencia L
    Rev Clin Esp; 1985 Jan; 176(1):13-7. PubMed ID: 2986206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum viscosity and chronic hepatopathies].
    Pavanel S; Dell'Anna L; Cappelletti P
    Quad Sclavo Diagn; 1983 Mar; 19(1):98-112. PubMed ID: 6675048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zinc and alcoholic liver cirrhosis].
    Floriani M; Genga A; Spalluto A
    G Clin Med; 1988 May; 69(5):341-5. PubMed ID: 3169462
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses].
    Shaposhnikova NA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2007; (5):46-50, 164. PubMed ID: 18389597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy.
    Güven K; Kelestimur F; Yücesoy M
    Eur J Med; 1993 Feb; 2(2):83-5. PubMed ID: 8258022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis.
    Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A
    Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
    Flisiak R; Pytel-Krolczuk B; Prokopowicz D
    Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
    Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
    Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
    Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
    Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thrombopoietin levels in thrombocytopenic patients with liver cirrhosis.
    Vyzantiadis T; Theodoridou S; Giouleme O; Evgenidis N; Vyzantiadis A; Garipidou V
    Haematologica; 2002 Aug; 87(8):890-1. PubMed ID: 12161370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.